Organisation paid for research Program year 2025 Source: CMS Open Payments

Sabal Eye Care

Neither a doctor nor a teaching hospital

Research payments

$144,177

30 payments

Through program year 2025, Sabal Eye Care is reported as receiving $144,177 in research payments, across 30 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$131,138	11
2023	Research	$266	4
2022	Research	$587	9
2021	Research	$193	4
2019	Research	$11,994	2

Breakdown

Who paid Research payments · program years 2019–2025

Oyster Point Pharma, Inc. $131,138 11 payments
Osmotica Pharmaceutical Corp. $11,994 2 payments
Johnson & Johnson Vision Care, Inc. $1,046 17 payments

Studies the money was for Research payments · program years 2019–2025

Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) $115,288 8 payments
Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia (VEGA-3) $15,850 3 payments
Rvl-203 $11,994 2 payments
6505 $314 4 payments
Pilot clinical evaluation of investigational contact lenses $187 2 payments
Clinical evaluation of approved and investigational contact lenses $79 2 payments
CR-6491/Pilot clinical evaluation of investigational contact lenses $79 1 payment
CR-6479/Clinical evaluation of investigational contact lenses $79 1 payment
CR-6468/Pilot clinical evaluation of approved and investigational contact lenses $79 1 payment
CR-6484/Clinical evaluation of approved and investigational contact lenses $39 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.